+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Vaccines Market Research Report by Indication (Anal Cancer, Cervical Cancer, and Genital Warts), Distribution Channel, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 142 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5124459
UP TO OFF until Dec 31st 2022
The United States Vaccines Market size was estimated at USD 9,785.94 million in 2021, USD 11,062.33 million in 2022, and is projected to grow at a CAGR 9.51% to reach USD 16,883.21 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Indication, the market was studied across Anal Cancer, Cervical Cancer, Genital Warts, Oropharyngeal Cancer, Penile Cancer, Vaginal Cancer, and Vulvar Cancer.
  • Based on Distribution Channel, the market was studied across Government Entities, Physician Distributors, Physicians, Public & Private Alliances, and Wholesalers.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Vaccines market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vaccines Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Vaccines Market, including Abbott Laboratories Ltd, Astellas Pharma Inc., AstraZeneca PLC, Bharat Biotech International Limited, CSL Limited, Daiichi Sankyo Co., Ltd., Emergent BioSolutions, Inc., GlaxoSmithKline PLC, Inovio Pharmaceuticals, Inc., Johnson & Johnson, Merck KGaA, Mitsubishi Tanabe Pharma Corporation, Novartis AG, Novavax, Inc., Panacea Biotec Ltd, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Company Limited.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Vaccines Market?
4. What is the competitive strategic window for opportunities in the United States Vaccines Market?
5. What are the technology trends and regulatory frameworks in the United States Vaccines Market?
6. What is the market share of the leading vendors in the United States Vaccines Market?
7. What modes and strategic moves are considered suitable for entering the United States Vaccines Market?
Frequently Asked Questions about the U.S. Vaccines Market

What is the estimated value of the U.S. Vaccines Market?

The U.S. Vaccines Market was estimated to be valued at $9785.94 Million in 2021.

What is the growth rate of the U.S. Vaccines Market?

The growth rate of the U.S. Vaccines Market is 9.5%, with an estimated value of $16883.21 Million by 2027.

What is the forecasted size of the U.S. Vaccines Market?

The U.S. Vaccines Market is estimated to be worth $16883.21 Million by 2027.

Who are the key companies in the U.S. Vaccines Market?

Key companies in the U.S. Vaccines Market include Abbott Laboratories Ltd, Astellas Pharma Inc., AstraZeneca PLC, Bharat Biotech International Limited, CSL Limited, Daiichi Sankyo Co., Ltd., Emergent BioSolutions, Inc., GlaxoSmithKline PLC and Johnson & Johnson.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Vaccines Market, by Indication
6.1. Introduction
6.2. Anal Cancer
6.3. Cervical Cancer
6.4. Genital Warts
6.5. Oropharyngeal Cancer
6.6. Penile Cancer
6.7. Vaginal Cancer
6.8. Vulvar Cancer
7. Vaccines Market, by Distribution Channel
7.1. Introduction
7.2. Government Entities
7.3. Physician Distributors
7.4. Physicians
7.5. Public & Private Alliances
7.6. Wholesalers
8. California Vaccines Market9. Florida Vaccines Market10. Illinois Vaccines Market11. New York Vaccines Market12. Ohio Vaccines Market13. Pennsylvania Vaccines Market14. Texas Vaccines Market
15. Competitive Landscape
15.1. Fpnv Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, by Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Abbott Laboratories Ltd
16.2. Astellas Pharma Inc.
16.3. Astrazeneca plc
16.4. Bharat Biotech International Limited
16.5. Csl Limited
16.6. Daiichi Sankyo Co., Ltd.
16.7. Emergent Biosolutions, Inc.
16.8. GlaxoSmithKline plc
16.9. Inovio Pharmaceuticals, Inc.
16.10. Johnson & Johnson
16.11. Merck KGaA
16.12. Mitsubishi Tanabe Pharma Corporation
16.13. Novartis Ag
16.14. Novavax, Inc.
16.15. Panacea Biotec Ltd
16.16. Pfizer Inc.
16.17. Sanofi Sa
16.18. Serum Institute of India Pvt. Ltd.
16.19. Takeda Pharmaceutical Company Limited
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES VACCINES MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VACCINES MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES VACCINES MARKET DYNAMICS
FIGURE 8. UNITED STATES VACCINES MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES VACCINES MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VACCINES MARKET SIZE, BY INDICATION, 2027
FIGURE 11. UNITED STATES VACCINES MARKET SIZE, BY ANAL CANCER, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES VACCINES MARKET SIZE, BY ANAL CANCER, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES VACCINES MARKET SIZE, BY CERVICAL CANCER, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES VACCINES MARKET SIZE, BY CERVICAL CANCER, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES VACCINES MARKET SIZE, BY GENITAL WARTS, 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES VACCINES MARKET SIZE, BY GENITAL WARTS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES VACCINES MARKET SIZE, BY OROPHARYNGEAL CANCER, 2019-2027 (USD MILLION)
FIGURE 18. UNITED STATES VACCINES MARKET SIZE, BY OROPHARYNGEAL CANCER, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES VACCINES MARKET SIZE, BY PENILE CANCER, 2019-2027 (USD MILLION)
FIGURE 20. UNITED STATES VACCINES MARKET SIZE, BY PENILE CANCER, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES VACCINES MARKET SIZE, BY VAGINAL CANCER, 2019-2027 (USD MILLION)
FIGURE 22. UNITED STATES VACCINES MARKET SIZE, BY VAGINAL CANCER, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES VACCINES MARKET SIZE, BY VULVAR CANCER, 2019-2027 (USD MILLION)
FIGURE 24. UNITED STATES VACCINES MARKET SIZE, BY VULVAR CANCER, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 26. UNITED STATES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 28. UNITED STATES VACCINES MARKET SIZE, BY GOVERNMENT ENTITIES, 2019-2027 (USD MILLION)
FIGURE 29. UNITED STATES VACCINES MARKET SIZE, BY GOVERNMENT ENTITIES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 30. UNITED STATES VACCINES MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, 2019-2027 (USD MILLION)
FIGURE 31. UNITED STATES VACCINES MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 32. UNITED STATES VACCINES MARKET SIZE, BY PHYSICIANS, 2019-2027 (USD MILLION)
FIGURE 33. UNITED STATES VACCINES MARKET SIZE, BY PHYSICIANS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES VACCINES MARKET SIZE, BY PUBLIC & PRIVATE ALLIANCES, 2019-2027 (USD MILLION)
FIGURE 35. UNITED STATES VACCINES MARKET SIZE, BY PUBLIC & PRIVATE ALLIANCES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES VACCINES MARKET SIZE, BY WHOLESALERS, 2019-2027 (USD MILLION)
FIGURE 37. UNITED STATES VACCINES MARKET SIZE, BY WHOLESALERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 38. CALIFORNIA VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. FLORIDA VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. ILLINOIS VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. NEW YORK VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. OHIO VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. PENNSYLVANIA VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. TEXAS VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. UNITED STATES VACCINES MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 46. UNITED STATES VACCINES MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 47. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES VACCINES MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES VACCINES MARKET SIZE, BY ANAL CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES VACCINES MARKET SIZE, BY CERVICAL CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES VACCINES MARKET SIZE, BY GENITAL WARTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES VACCINES MARKET SIZE, BY OROPHARYNGEAL CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES VACCINES MARKET SIZE, BY PENILE CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES VACCINES MARKET SIZE, BY VAGINAL CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES VACCINES MARKET SIZE, BY VULVAR CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES VACCINES MARKET SIZE, BY GOVERNMENT ENTITIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES VACCINES MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES VACCINES MARKET SIZE, BY PHYSICIANS, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES VACCINES MARKET SIZE, BY PUBLIC & PRIVATE ALLIANCES, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES VACCINES MARKET SIZE, BY WHOLESALERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. CALIFORNIA VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 20. CALIFORNIA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 21. CALIFORNIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 22. FLORIDA VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 23. FLORIDA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 24. FLORIDA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 25. ILLINOIS VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 26. ILLINOIS VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 27. ILLINOIS VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 28. NEW YORK VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 29. NEW YORK VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 30. NEW YORK VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 31. OHIO VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 32. OHIO VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 33. OHIO VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 34. PENNSYLVANIA VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 35. PENNSYLVANIA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 36. PENNSYLVANIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 37. TEXAS VACCINES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 38. TEXAS VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 39. TEXAS VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 40. UNITED STATES VACCINES MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 41. UNITED STATES VACCINES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 42. UNITED STATES VACCINES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 43. UNITED STATES VACCINES MARKET RANKING
TABLE 44. UNITED STATES VACCINES MARKET SHARE, BY KEY PLAYER, 2021
TABLE 45. UNITED STATES VACCINES MARKET MERGER & ACQUISITION
TABLE 46. UNITED STATES VACCINES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 47. UNITED STATES VACCINES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 48. UNITED STATES VACCINES MARKET INVESTMENT & FUNDING
TABLE 49. UNITED STATES VACCINES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 50. UNITED STATES VACCINES MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories Ltd
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bharat Biotech International Limited
  • CSL Limited
  • Daiichi Sankyo Co., Ltd.
  • Emergent BioSolutions, Inc.
  • GlaxoSmithKline PLC
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Merck KGaA
  • Mitsubishi Tanabe Pharma Corporation
  • Novartis AG
  • Novavax, Inc.
  • Panacea Biotec Ltd
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Company Limited

Methodology

Loading
LOADING...